These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30796705)

  • 21. Outcome after prenatal diagnosis of congenital anomalies of the kidney and urinary tract.
    Nef S; Neuhaus TJ; Spartà G; Weitz M; Buder K; Wisser J; Gobet R; Willi U; Laube GF
    Eur J Pediatr; 2016 May; 175(5):667-76. PubMed ID: 26805407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast enhanced spiral computerized tomography in patients with chronic obstructive uropathy and normal serum creatinine: a single session for anatomical and functional assessment.
    El-Ghar ME; Shokeir AA; El-Diasty TA; Refaie HF; Gad HM; El-Dein AB
    J Urol; 2004 Sep; 172(3):985-8. PubMed ID: 15311018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder contractility index in posterior urethral valve: A new marker for early prediction of progression to renal failure.
    Ansari MS; Nunia SK; Bansal A; Singh P; Sekhon V; Singh D; Soni R; Yadav P
    J Pediatr Urol; 2018 Apr; 14(2):162.e1-162.e5. PubMed ID: 29496422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern of clinical presentation of congenital anomalies of the kidney and urinary tract among infants and children.
    Soliman NA; Ali RI; Ghobrial EE; Habib EI; Ziada AM
    Nephrology (Carlton); 2015 Jun; 20(6):413-8. PubMed ID: 25645028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for end stage renal disease in children with posterior urethral valves.
    DeFoor W; Clark C; Jackson E; Reddy P; Minevich E; Sheldon C
    J Urol; 2008 Oct; 180(4 Suppl):1705-8; discussion 1708. PubMed ID: 18708224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of renal function after neonatal urinary ascites due to obstructive uropathy.
    De Vries SH; Klijn AJ; Lilien MR; De Jong TP
    J Urol; 2002 Aug; 168(2):675-8. PubMed ID: 12131347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for renal failure in children with non-glomerular nephropathies.
    Litwin M
    Pediatr Nephrol; 2004 Feb; 19(2):178-86. PubMed ID: 14685838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicoureteral reflux, or ureterovesical junction obstruction.
    Herz D; Merguerian P; McQuiston L
    J Pediatr Urol; 2014 Aug; 10(4):650-4. PubMed ID: 25155409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.
    Mehls O; Lindberg A; Haffner D; Schaefer F; Wühl E; ;
    Pediatr Nephrol; 2015 Dec; 30(12):2145-51. PubMed ID: 26198275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insignificant impact of VUR on the progression of CKD in children with CAKUT.
    Ishikura K; Uemura O; Hamasaki Y; Nakai H; Ito S; Harada R; Hattori M; Ohashi Y; Tanaka R; Nakanishi K; Kaneko T; Iijima K; Honda M;
    Pediatr Nephrol; 2016 Jan; 31(1):105-12. PubMed ID: 26404649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression to end-stage renal disease in children with obstructive uropathy.
    Warshaw BL; Edelbrock HH; Ettenger RB; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    J Pediatr; 1982 Feb; 100(2):183-7. PubMed ID: 7057325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the applicability of three prediction equations for estimating glomerular filtration rate in children with chronic kidney disease].
    Wang F; Yao Y; Zhu SN; Huang JP; Xiao HJ; Ding J; Sai YP
    Zhonghua Er Ke Za Zhi; 2010 Nov; 48(11):855-9. PubMed ID: 21215031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Obstructive uropathy in childhood].
    Balster S; Schiborr M; Brinkmann OA; Hertle L
    Aktuelle Urol; 2005 Aug; 36(4):317-28. PubMed ID: 16110405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with long-term progression of pediatric chronic kidney disease of nonglomerular etiologies.
    Chen CC; Chou HH; Chiou YY
    J Formos Med Assoc; 2019 Oct; 118(10):1423-1429. PubMed ID: 30616992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Masked obstructive uropathy of the upper urinary tract in childhood].
    Thon A; Thon W; Altwein JE
    Monatsschr Kinderheilkd; 1985 Sep; 133(9):708-11. PubMed ID: 3903476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell type specific changes in BMP-7 expression contribute to the progression of kidney disease in patients with obstructive uropathy.
    Manson SR; Song JB; Guo Q; Liapis H; Austin PF
    J Urol; 2015 May; 193(5 Suppl):1860-1869. PubMed ID: 25813565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.
    Li B; Zhang Y; Wang F; Nair V; Ding F; Xiao H; Yao Y; Kretzler M; Ju W; Ding J
    Pediatr Nephrol; 2018 Oct; 33(10):1731-1739. PubMed ID: 29948307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic expression of Th2 cytokines in urothelium of congenital ureteropelvic junction obstruction.
    Chiou YY; Shieh CC; Cheng HL; Tang MJ
    Kidney Int; 2005 Feb; 67(2):638-46. PubMed ID: 15673311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Would the indwelling internal ureteral stent influence renal function despite relief of benign ureteral obstruction?
    Harraz AM; EL-Nahas AR; Zahran MH; Abol-Enein H
    J Endourol; 2014 Feb; 28(2):243-7. PubMed ID: 24032464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental congenital obstructive uropathy.
    Peters CA; Mandell J
    Urol Clin North Am; 1990 May; 17(2):437-47. PubMed ID: 2186545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.